The discussion about pharmaceutical companies’ adoption of digital health tends to revolve around what Big Pharma businesses are doing. But at the annual Health 2.0 Fall conference this week, BTG Digital Health Innovation Director Amanda Goltz made a case for the advantages of being a smaller player.
Goltz noted that the UK-based specialty pharma company’s relatively small size meant it could be more agile.
Goltz drew attention to BTG’s collaboration with Tonic Health — a digital health business that has moved from engaging patients to fill out electronic medical forms in a doctor’s office to working with payers as well as for pharma companies. With BTG, Tonic is providing support on clinical trials in interventional oncology and patient-reported outcomes in interventional medicine. She also highlighted BTG’s work with Deloitte to develop Snakebite 911 — an app to support for its snake bite antivenom. But it was with a new initiative to support cancer patients where she viewed the company’s size as an advantage.
The artificial intelligence offshoot of Google has paired up with University College London Hospitals NHS Foundation Trust for a research project.DeepMind Health announced that it will be receiving anonymised data from the trust for a research partnership into head and neck cancer.The five-year collaboration will use around 700 anonymised CT and MRI scans of former patients, dating back to 2008, and additional data relating to approximate age, anatomy location, cancer type and radiotherapy received.
In today’s healthcare environment, insurers may see the value of digital health, but decades-old infrastructure, workflows and IT departments may be holding them back from fully embracing the technological innovations that doctors and patients want and need. And breaking through those roasblocks starts with asking the patients what they want.
During the Healthcare Innovation Summit at Stanford MedX, payers, providers, investors, entrepreneurs and patients gathered to discuss the future of digital healthcare that prizes the consumer experience above all. The biggest hurdle to embracing digital, it seems, is accepting the fact that legacy systems must be knocked down to clear the way for operating methods that will embody the value-based care everyone is striving for
The market for women-specific digital health tools is ripe, buttressed by the growing number of women tech entrepreneurs, the desire for family planning data, and increasing call for accommodations for women in the workplace, according to a panel at TechCrunch Disrupt in San Francisco. While women haven’t historically been the focus in technology – both in the workforce or in the consumer target – that is changing, the panel concurred. Not only are the combined industries of family planning, breastfeeding and infant nutrition worth several hundred billion dollars per year, but people are becoming more comfortable talking about it.
"This is the first time ever at TechCrunch Disrupt that we’ve been able to talk about women’s reproductive health, which is a huge issue that affects, you know, half of the population,” said TechCrunch moderator Sarah Buhr. “Why has it taken so long, with all the health tech, with all the technology in general, to start looking at women’s health?"
actice providing 24/7 immediate access to top doctors and their knowledge via video, text, or voice is expanding its digital health network to the UK. The new London-based company named HealthTap UK will features new apps and website specifically for British doctors and patients to supplement and complement the care already provided to citizens by the United Kingdom’s National Health Service (NHS).
More and more, direct-to-consumer wearables companies are moving into business-to-business healthcare markets. It's not exactly a surprising move -- the potential for consumer technology to encourage healthier lifestyle choices is a core thesis of digital health, and one that could have big implications for healthcare as it faces a rise in chronic conditions. Nonetheless, over the course of the past year MobiHealthNews has noticed a creeping trend of the big names in consumer-facing digital health putting more resources behind their B2B programs.
Take Fitbit itself, for example. In the company's first quarter earnings call, CEO James Park wasn't shy about trumpeting the healthcare opportunity, stopping just shy of promising a regulated device.
As mobile health technology has proliferated, federal regulatory authorities have taken notice. In particular, over the last five years the U.S. Food and Drug Administration (FDA) has been honing its approach to mobile apps and has released a series of documents that provide helpful guidelines to developers of healthtech apps. In particular, the FDA sorts mobile apps into three buckets:apps that are not “medical devices,” and so are not subject to the Federal Food, Drug and Cosmetic Act (the FD&C Act);apps that are medical devices, ostensibly subject to the FD&C Act, but that pose a low enough risk to the public that the FDA has determined not to enforce the FD&C Act with respect to them; andapps that are medical devices, subject to the FD&C Act, and over which the FDA intends to apply its regulatory authority.
Patients afflicted with chronic pain might wish for another body but it turns out that sitting next to an image of their own body could do the job.
A virtual reality “out of body” illusion affords more temporary relief than powerful painkillers, a study suggests, with patients finding that their pain diminished by more than a third.
About one in ten adults in Britain is thought to suffer from some form of chronic pain, although the phenomenon is only partially understood.
Over the past decade experiments have suggested that the symptoms have as much to do with the mind as with any problem in the body, leading researchers and virtual reality companies to test immersive computer games and other distractions as possible treatments.
In our line of work we see countless value propositions that digital health companies strive to (or claim to) deliver.
Maybe we’ve had one too many summertime margaritas, but lately this value proposition barrage has got us thinking: It seems that there is something missing in the digital health value chain.
Clinically and commercially validated digital health interventions are supposed to be paving the way towards success and bringing return on investment to the health stakeholder. This is what we’re all trying to do, right? The question is though: what exactly is the ROI that digital health promises to bring?
With investments in the digital health marketplace accelerating at a rapid pace, Astellas Pharma Inc. and DigiTx Partners LLC have announced that Astellas has launched DigiTx Partners, a digital health investment company in partnership with MPM Capital, Inc.
DigiTx Partners will invest in the digital health space broadly, with a special focus on companies which create solutions that improve patient outcomes and provide substantial synergy with a broader pharma business. Although the emphasis will be on earlier stage companies, investments will be made in both start-ups and growth stage companies.
At this year’s recent annual Institute and Expo of the America’s Health Insurance Plans, three central themes emerged from its sessions: digital health impacts, consumer engagement trends, and business and care transformation.Here’s a closer look at what each theme means from an industry perspective, the overall messages that were delivered on each theme throughout the conference, as well some potential challenges ahead that the industry should anticipate.
“Don’t ever forget that you’re weird.”Not exactly what I expected to hear, years ago, on the first day of my first business school marketing class. This advice is a good reminder that designing for oneself, while straightforward and enticing, will not have widespread impact.When it comes to healthcare and wellness, the population of people needing support is quite diverse. Not everyone has adequate health insurance, access to specialists, disposable income for a gym membership, education about proper nutrition, a reliable personal support system or convenient internet access to receive messages from providers.
The Apple Watch Series 2 may have been a big leap for Apple Inc.'s wearable device, but the tech company has an even bigger shift planned. The Cupertino based company wants to change smoothly the Apple Watch from a fitness tracking device to a fully developed medical diagnostic tool.
A whole panoply of new sleep apps, sites, and devices are waking up the digital health industry—and they go far beyond the tracker market.The digital health sector experienced record highs for funding in the last two years, with 2015 reaching $4.5 billion. According to a recent study, the market for devices that help diagnose and treat the 40 million Americans suffering from sleep disorders is estimated to reach $125.8 million in 2017.
Step goals, calorie counting, logging running routes, they all produce a lot of data in health and fitness apps. But how do you make it useful? It's a question that has been wrestled with this week after a study from the University of Pittsburgh found that out of two Weight Watchers groups trying to lose weight, the group using only healthy eating and exercise plans lost more than the group using a BodyMedia fitness tracking wearable.The report itself didn't offer any conclusions as to why the tracker hindered the nutrition and fitness plans rather than helped. Part of the reason is no doubt that a tracker alone can't change your habits.The weight loss market is predicted to be worth $200 billion by 2019 so tech companies have a big incentive to understanding this first, second and possibly third generation wearable tech problem. Finding a solution is the tougher part. As well as software engineers, many wearable companies are turning to behavior and data scientists and even psychologists to find ways to make their devices make a difference.
Teva Pharmaceuticals’ collaboration with Intel this week to develop a way to track Huntington’s disease patients through a combined platform of wearables and machine learning platform is a fascinating development. The partnership underscores the pharma industry’s growing interest in using digital health to develop a more complete understanding of patient populations to advance drug development. Neurodegenerative diseases represent a particularly interesting area for wearables to come into play as clinicians and researchers seek to better understand disease progression.
The point is to get a fuller picture of patients between doctor appointments. The machine learning component is designed to make sense of the enormous amount of data the study will gather.
How could health care be more like Uber? What could it learn from Airbnb? Sitting in the heart of Silicon Valley, Medicine X would hardly be complete without a panel mentioning such companies. Luckily, Jonathan Bush‘s Saturday morning keynote embraced the questions and discussed bringing “the network effect” to health care, with a rollicking sense of humor to boot.Bush, founder and CEO of athenahealth, extolled the network as the principle by which supply and demand can be re-calibrated in real time, just like Uber does with auto transport and Airbnb does with temporary housing. Who is looking for what? Where, when, and at what price? What resources are sitting unused? By collecting this data via smart phones, and connecting such clients with providers who can meet their needs, health care could be immensely more efficient, responsive, and affordable, Bush argued.
Apple's ambitions in the health sector continue to expand, with its digital health team making its first known acquisition—personal health data startup Gliimpse, Fast Company has learned.Silicon Valley-based Gliimpse has built a personal health data platform that enables any American to collect, personalize, and share a picture of their health data. The company was started in 2013 by Anil Sethi and Karthik Hariharan. Sethi is a serial entrepreneur who has spent the past decade working with health startups, after taking his company Sequoia Software public in 2000. He got his start as a systems engineer at Apple in the late 1980s.
It’s 2021. There has been a steady trickle of stories about what happens to people’s health data. There’s no concrete evidence of harm in any of these stories, but a crisis of confidence has built up over time. One hospital has been the subject of a cyberattack, but it is not yet clear whether sensitive data has been stolen and deciphered.Controversy about the use of health data is nothing new. Five years earlier in 2016, 2.2% of patients had exercised their right to opt out of data being shared beyond the NHS information centre after a botched attempt to link up information from patients’ GP records and hospital activity records.
In a report published today the charity said that technology delivered via smartphones, including ‘smart inhalers’, apps that help individuals avoid triggers and remote monitoring, would revoluntionise asthma care and ease pressure on the NHS.The report, Connected asthma: how technology will transform care, said immediate action should be taken to ensure every person with asthma has an action plan available to them digitally. These action plans should eventually be incorporated into shared patient records.
The Apple rumor mill is rolling again, this time with reports of a new forthcoming health device. According to Apple Insider, via Taiwanese paper Economic Daily News, the new product, two years in the making, will "accurately collect users' personal daily life including heart rate, pulse, blood sugar changes and other information." It's supposedly set for a 2016 launch.
Details about the form of this new device were hazy -- it could be a new wearable, a handheld device, or perhaps a strap or set of straps for the Apple Watch that expand the device's existing health-sensing capabilities.
The Olympics aren't just for athletes. It's also an opportunity for sports tech companies – including makers of vitals-monitoring wearables, fitness and training apps, and other digital tools – to show off their technology on an international stage. In Rio, athletes are looking for every edge to compete, and that includes the latest gadgets.
Samsung offered gifts to every athelete and included a little bit of digital health flair. As reported by Engadget, Samsung gifted 12,500 Olympic athletes with a special edition Galaxy S7 Edge phone. In addition to an Olympics-inspired design and a built-in Rio Olympics app, the phones came with Samsung's Gear IconX heartrate-tracking earbuds, which can send data to Samsung's S Health app.
There has been an explosion of digital health startups in recent years. The market is expected to reach $233.3 billion by 2020, with the primary driver coming from the mobile health market.Companies are springing up to offer solutions for the escalating costs of health care, wellness, physician shortages and the need for improved prevention and management of expensive chronic conditions.
Healthcare has been understandably late to the widespread adoption of digital technology. Extremely restrictive regulations, the presence of multiple key stakeholders, a slow-to-adopt culture and other challenges distinguish healthcare from the retail and finance sectors, which have flourished with their implementations of digital technologies. But pharmaceutical companies (pharma) inhabit a unique position, situated between patients, prescribers and payers, allowing them to gain maximum benefits from a wide array of digital offerings.
Digital health executives and professors testified about the ways they think federal regulation needs to change to create a robust digital health industry while still protecting the safety and wellbeing of patients.The conversation spanned various regulatory bodies and federal programs including HIPAA, the FDA, FTC and Medicare.“The regulatory framework for most of these apps is complicated and in some cases troubling,” Nicolas Terry, a law professor at Indiana University said in his prepared testimony. “The oversimplified binary of regulation versus innovation is a poor frame. Rather, we have a current technological space that is subject to both over-regulation and under-regulation.”
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.